FOXP3 and cancer: Mean ± SEM percentage ofCD4+CD25+FOXP3+CD45RA+ phenotype was 24.05 ±5.5%, 21.36 ± 4.7%, and 9.51 ± 3.6% respectively afterco-culturing with cancer-ASCs and normal-ASCs and inthe control group (Fig .3A).